Diffuse large B-cell lymphoma

There are 61 papers on diffuse large B-cell lymphoma in aging research: 5 trials and 45 observational studies in people, 5 in animals, 2 reviews. The newest story, Nov 16, 2026: “Heart failure after anthracyclines in older adults with two lymphomas”.

Disease

61 papers study it10 more mention it10 findings

4 new papers in 30 daysSee all 71 papers on diffuse large B-cell lymphoma

“indirect pesticide exposure increased risks for chronic lymphoid leukemia/small lymphocytic lymphoma (HR=1.69, 95%CI=1.08-2.64) and diffuse large-B cell lymphoma (HR=1.84, 95%CI=1.08-3.15)”
Lymphoid malignancies and agricultural exposures: Assessing subtype-specific risks in the AGRICAN prospective cohortEnvironmental research2026doi:10.1016/j.envres.2026.126123
  • Human trial5
  • Humans45
  • Animals5

Effects

4

Mortality

upin humans1

1 study
  1. Diffuse large B-cell lymphoma is linked with higher mortality in humans after HF onset.

    “After HF onset, patients with LBCL had consistently higher all-cause (but not cardiovascular) mortality than comparators.”

    Humansafter HF onset

    Incidence, timing, and prognosis of heart failure after treatment for large B-cell lymphoma in Sweden during 2007-2022

    Blood advances

Cell killing (cytotoxicity)

downin humans1

1 study
  1. Diffuse large B-cell lymphoma is linked with lower cell killing (cytotoxicity) in humans (against DLBCL cells compared to those from healthy donors).

    “MAIT cells from DLBCL patients showed diminished cytotoxicity against DLBCL cells compared to those from healthy donors.”

    Humansagainst DLBCL cells compared to those from healthy donors

    Circulating mucosa-associated invariant T cells are decreased and have impaired function in patients with diffuse large B-cell lymphoma

    Translational oncology

More on Cell killing (cytotoxicity)

Cellular senescence

upin humans1

1 study
  1. Diffuse large B-cell lymphoma is linked with cellular senescence in circulating MAIT cells from DLBCL patients.

    “circulating MAIT cells from DLBCL patients exhibited proapoptotic and senescent phenotypes and demonstrated dysfunction”

    Humansin circulating MAIT cells from DLBCL patients

    Circulating mucosa-associated invariant T cells are decreased and have impaired function in patients with diffuse large B-cell lymphoma

    Translational oncology

More on Cellular senescence

Circulating MAIT cells

downin humans1

1 study
  1. Diffuse large B-cell lymphoma is linked with lower circulating MAIT cells in DLBCL patients compared to age-matched healthy controls.

    “revealed a significant reduction in the frequency of circulating MAIT cells in DLBCL patients compared to age-matched healthy controls.”

    Humansin DLBCL patients compared to age-matched healthy controls

    Circulating mucosa-associated invariant T cells are decreased and have impaired function in patients with diffuse large B-cell lymphoma

    Translational oncology

More on Circulating MAIT cells

Upstream

1

Telomere length

no changein silico1

1 study
  1. Telomere length showed no clear effect on diffuse large B-cell lymphoma in silico.

    “However, there was no association between TL and diffuse large B-cell lymphoma, follicular lymphoma, or mature T/natural Killer-cell lymphoma”

    In silico

    The causal effect of telomere length on the risk of malignant lymphoma: A Mendelian randomization study

    Medicine

More on Telomere length

Associations

5

Indirect pesticide exposure

upin humans1HR 1.84

1 study
  1. Indirect pesticide exposure is associated with diffuse large B-cell lymphoma In winegrowing (HR=1.84, 95%CI=1.08-3.15).

    “indirect pesticide exposure increased risks for chronic lymphoid leukemia/small lymphocytic lymphoma (HR=1.69, 95%CI=1.08-2.64) and diffuse large-B cell lymphoma (HR=1.84, 95%CI=1.08-3.15)”

    HumansIn winegrowing

    Lymphoid malignancies and agricultural exposures: Assessing subtype-specific risks in the AGRICAN prospective cohort

    Environmental research

More on Indirect pesticide exposure

Basal metabolic rate

upin humans1

1 study
  1. Basal metabolic rate is linked with a higher risk of diffuse large B-cell lymphoma in humans (Mendelian randomization after excluding traits with horizontal pleiotropy).

    “BMR, TFFM, and TPM increased diffuse large B cell lymphoma risk”

    HumansMendelian randomization after excluding traits with horizontal pleiotropy

    Reevaluating the obesity paradox across diverse disease outcomes: A Mendelian randomization study

    Medicine

More on Basal metabolic rate

ING5

downin mice1

1 study
  1. ING5 lowers the risk of diffuse large B-cell lymphoma in mice (shown by knockout) (6-fold higher rate).

    “ING5 KO mice developed germinal centre diffuse large B-cell lymphomas at a rate 6-fold higher than control mice at 18 months of age”

    Animalsshown by knockout

    Knockout of the ING5 epigenetic regulator confirms roles in stem cell maintenance and tumor suppression in vivo

    PloS one

More on ING5

Metformin

upin humans1HR 1.76

1 study
  1. Metformin is linked with a higher risk of diffuse large B-cell lymphoma in humans (compared with the reference group) (HR 1.76, 95% CI 1.13-2.75).

    “Additionally, an increased risk of DLBCL [HR = 1.76, 95% CI (1.13-2.75)] was found in metformin users compared to the reference group.”

    Humanscompared with the reference groupfemales

    Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative

    International journal of cancer

More on Metformin

Type 2 diabetes

upin humans1HR 1.38

1 study
  1. Type 2 diabetes is linked with a higher risk of diffuse large B-cell lymphoma in humans (compared with the reference group of nondiabetics and untreated diabetes) (38% higher risk; HR 1.38, 95% CI 1.06-1.81).

    “Women with T2DM and with self-reported oral medication use had 38% and 55% higher risk of DLBCL”

    Humanscompared with the reference group of nondiabetics and untreated diabetesfemales

    Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative

    International journal of cancer

More on Type 2 diabetes

Trial sponsors

Latest

Dec 2025: 2Jan 2026: 0Feb 2026: 4Mar 2026: 2Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 1Nov 2026: 415 papers in 12 months
Cardio-oncology

Heart failure after anthracyclines in older adults with two lymphomas

Among 13,401 older patients without prior heart failure, treated with anthracyclines for either of two lymphomas, estimated heart failure incidence reached 14.2% at two…Among 13,401 older patients without prior heart failure, treated with anthracyclines for either of two lymphomas, estimated heart failure incidence reached 14.2% at two years.

Cohort · 13,401 peopleLymphoma
Cancer Epidemiology, Biomarkers & Prevention

Body roundness linked to higher cancer risk after menopause

An observational study followed 144,865 women past menopause for a median of 17.9 years, linking a higher waist-and-height measure to several cancers.An observational study followed 144,865 women past menopause for a median of 17.9 years, linking a higher waist-and-height measure to several cancers.

Cohort · 144,865 peopleCancer

See all 71 papers on diffuse large B-cell lymphoma